REVB Revelation Biosciences Corp: Market Valuation
Revelation Biosciences is promoting its Gemini therapy through partnerships with scientific centers, enhancing its investment appeal. This chart of share prices at a market capitalization of 0.00 complements data on management's efforts to develop allergy treatments. The startup is currently seeking to accelerate trials to outpace industry behemoths and capture vacant niches.
Comprehensive metric breakdowns and analytics for Revelation Biosciences Corp (REVB)
- current price and projected stock value:
- company stock capitalization data:
- business book valuation details:
- business debt structure and liquidity details:
Total Debt to Capital Revelation Biosciences|REVB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Revelation Biosciences|REVB - Company Aggregate Debts|Debt to Book Capitalization Ratio Revelation Biosciences Corp|REVB - Company Long-Term Loans and Borrowings|Company Short-Term Debt Revelation Biosciences|Quick Ratio revbiosciences.com
- financial results and valuation multiples details:
REVB - Net Profit|Future Profit Revelation Biosciences|REVB - Company Value to Net Income|Forward P/E Multiple Revelation Bio|REVB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences Corp|REVB - Operating profit before deduction of amortization|Earnings per share for the last twelve months Revelation Biosciences|REVB - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months revbiosciences.com|REVB - Earnings growth in current year|Net earnings per share growth forecast for next year Revelation Biosciences
Fundamental company analysis:REVB (Revelation Biosciences, Inc.)
Market capitalization measures the aggregate value of assets through the lens of current market expectations and the cost of capital. Analyzing the public capitalization chart of Revelation Biosciences (REVB) allows for the real-time tracking of multiple compression. This metric objectifies the financial stability of the business in the absence of stable cash flows. For Revelation Biosciences (REVB), this serves as an indicator of investor confidence in the success of clinical trials. The trend of this indicator reflects the risks of rapid cash burn and the probability of patent disputes.
Key competitors
Market Capitalization ARGX (argenx)|BioNTech Inc. (BNTX) - Market Value|ABVX: Market Valuation|ADMA: Market Value|PTGX: Market Capitalization|IMVT (immunovant.com) - Market Value|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT - Market Value|Market Value JBIO (Aerovate Therapeutics Inc)|ACRS: Market Capitalization|Market Value kyvernatx.com (KYTX)|Market Valuation TLSA|Market Value CABA|Market Capitalization VTYX|THTX - Market Value|Market Value Avalo Therapeutics, Inc AVTX|eledon.com - Market Value|Agenus Inc. - Market Capitalization|CLYM - Market Capitalization|ZURA (Zura Bio) - Market Valuation|ATYR: Market Value|ADAG (Adagene Inc) - Market Capitalization|Ikena Oncology, Inc. (IMA) - Market Capitalization|Market Value Shattuck Labs, Inc. (STTK)|EQ - Market Value|Market Value Connect Biopharma Holdings Limited CNTB|IMUX: Market Capitalization|ATRA: Market Valuation|Market Value IFRX (InflaRx N.V.)|XFOR: Market Capitalization|ACET (Adicet Bio, Inc.) - Market Value|CELU (Celularity Inc) - Market Capitalization|INmune Bio Corporation (INMB) - Market Capitalization|Market Value Barinthus Biotherapeutics (BRNS)|KZR - Market Value|Market Value SAB Biotherapeutics, Inc. SABS|Market Capitalization Akari Therapeutics PLC (AKTX)|Enlivex Therapeutics, Ltd. - Market Capitalization|Q32 Bio Inc. (QTTB) - Market Valuation|GOVX: Market Capitalization|EDSA - Market Capitalization|IBIO (iBio) - Market Capitalization|Market Value Carisma Tx CARM|Market Value XTL Biopharmaceuticals, Ltd. (XTLB)|boltbio.com - Market Capitalization|Market Capitalization HCWB (HCW Biologics)|APVO - Market Valuation|AIM ImmunoTech Inc. - Market Capitalization|Market Value Aditxt|GRI Bio Corp (GRI) - Market Value|XRTX - Market Capitalization|Market Value Vyome Holdings Inc|INDP: Market Value|Market Capitalization SCNI|CALI - Market Value|Affimed N.V. - Market Valuation|Allakos Inc - Market Value|HOOKIPA - Market Capitalization|IGMS: Market Value|iTeos Therapeutics, Inc. (ITOS) - Market Value|Market Valuation OCEA (Ocean Biomedical Inc)|TCBP (TC BioPharm (Holdings) PLC) - Market Capitalization|THRD: Market Value
